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ABSTRACT: In the present study, we evaluated the possible involvement of 5-HT receptor 
subtypes and its inactivation system in MC3T3-E1 cells, an osteoblast cell line.  DOI, 
a 5-HT2A and 5-HT2C receptor selective agonist, as well as 5-HT increased proliferative 
activities of MC3T3-E1 cells in their premature period.  This effect of 5-HT on cell 
proliferation were inhibited by ketanserin, a 5-HT2A receptor specific antagonist.  Moreover, 
both DOI-induced cell proliferation and phosphorylation of ERK-1 and -2 proteins were 
inhibited by PD98059 and U0126, selective inhibitors of MEK.  Furthermore, treatment with 
fluoxetine, a 5-HT specific re-uptake inhibitor which inactivate the function of extracellular 
5-HT, significantly increased the proliferative activities of MC3T3-E1 cells.  Our data 
indicate that 5-HT fill the role for proliferation of osteoblast cells in their premature period. 
Notably, 5-HT2A receptor may be functionally expressed to regulate mechanisms underlying 
osteoblast cell proliferation, at least in part, through activation of ERK/MAPK pathways in 
MC3T3-E1 cells.
抄録　5-HT と同様に、5-HT2A および 5-HT2C 受容体選択的アゴニストである DOI は未
分化期の MC3T3-E1 細胞に対して増殖促進作用を示した。この 5-HT の作用は 5-HT2A
受容体特異的アンタゴニストであるケタンセリンによって阻害された。DOI による細
胞増殖および ERK-1、-2 タンパクのリン酸化は、MEK の阻害薬である PD98059 およ
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